Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones.

作者: Michael N. Dudley

DOI: 10.1016/0002-9343(91)90311-K

关键词:

摘要: The pharmacodynamic and pharmacokinetic properties of antibiotics have received increased attention in recent years, leading to optimization dosage regimens. In view these characteristics, certain fluoroquinolones may prove advantageous compared with other antimicrobials for treatment selected infections. Several new fluoroquinolone antimicrobial agents potency equal or greater than that beta-lactam against gram-negative aerobic bacilli, including Pseudomonas aeruginosa. vitro bactericidal activity compounds is more rapid the beta-lactams, often resembling aminoglycosides. Like aminoglycosides, but contrast exert a significant postantibiotic effect some strains P. aeruginosa Enterobacteriaceae. However, unlike many aminoglycoside similar activity, are effective both after oral parenteral administration. Important include differences extent variability absorption clearance, which determine vivo exposure drug. Drugs regimens result high degree exposure, particularly peak levels drug, be preferable because bacterial killing less selection drug-resistant bacteria.

参考文章(29)
Ebert Sc, Craig Wa, Killing and regrowth of bacteria in vitro: a review. Scandinavian Journal of Infectious Diseases. ,vol. 74, pp. 63- 70 ,(1990)
Victor Lorian, Antibiotics in laboratory medicine Published in <b>2005</b> in Philadelphia by Lippincott Williams & Wilkins. ,(2005)
J S Wolfson, D C Hooper, Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews. ,vol. 2, pp. 378- 424 ,(1989) , 10.1128/CMR.2.4.378
J S Wolfson, D C Hooper, The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy. ,vol. 28, pp. 581- 586 ,(1985) , 10.1128/AAC.28.4.581
Stephen H. Zinner, Michael N. Dudley, Deborah Gilbert, Bassignani Matthew, Effect of dose and schedule on cefoperazone pharmacodynamics in an in vitro model of infection in a neutropenic host. The American Journal of Medicine. ,vol. 85, pp. 56- 58 ,(1988) , 10.1016/0002-9343(88)90177-5
J Blaser, M N Dudley, D Gilbert, S H Zinner, Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin. Antimicrobial Agents and Chemotherapy. ,vol. 29, pp. 927- 929 ,(1986) , 10.1128/AAC.29.5.927
M. J. Ingerman, P. G. Pitsakis, A. F. Rosenberg, M. E. Levison, The Importance of Pharmacodynamics in Determining the Dosing Interval in Therapy for Experimental Pseudomonas Endocarditis in the Rat The Journal of Infectious Diseases. ,vol. 153, pp. 707- 714 ,(1986) , 10.1093/INFDIS/153.4.707
M. N. Dudley, J. Blaser, D. Gilbert, K. H. Mayer, S. H. Zinner, Combination Therapy with Ciprofloxacin plus Azlocillin against Pseudomonas aeruginosa: Effect of Simultaneous versus Staggered Administration in an In Vitro Model of Infection The Journal of Infectious Diseases. ,vol. 164, pp. 499- 506 ,(1991) , 10.1093/INFDIS/164.3.499